Moreover, Kaplan‐Meier analysis revealed that glioma patients with high levels of MATN1‐AS1 usually had poor overall survival in contrast to those with low MATN1‐AS1 levels (Figure 1D). Here, MATN1 is linked to central nervous system cancer.